| 5 mins | 30 mins | Hourly | Daily | Weekly | 
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL | 
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.11▲ | 1.11▲ | 1.11▲ | 1.15▼ | 1.09▲ | 
| MA10 | 1.11▲ | 1.11▲ | 1.11▲ | 1.16▼ | 1.09▲ | 
| MA20 | 1.12▲ | 1.12▲ | 1.13▼ | 1.11▲ | 1.19▼ | 
| MA50 | 1.14▼ | 1.16▼ | 1.17▼ | 1.10▲ | 1.22▼ | 
| MA100 | 1.16▼ | 1.15▼ | 1.11▲ | 1.21▼ | 1.50▼ | 
| MA200 | 1.17▼ | 1.10▲ | 1.10▲ | 1.18▼ | 1.25▼ | 
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.001▲ | -0.001▼ | 0.003▲ | 0.001▲ | 
| RSI | 52.377▲ | 49.555▼ | 48.389▼ | 51.321▲ | 47.936▼ | 
| STOCH | 47.619 | 46.131 | 31.548 | 38.181 | 26.654 | 
| WILL %R | 0.000▲ | -22.222▲ | -22.222▲ | -64.650 | -70.693 | 
| CCI | 128.889▲ | 72.727 | 44.413 | -8.657 | 0.938 | 
| Monday, October 20, 2025 11:38 PM Detailed price information for Cardiol Therapeutics Inc (CRDL-T) from The Globe and Mail including charting and trades. | 
| Friday, October 17, 2025 02:19 PM Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company advancing ... | 
| Friday, October 17, 2025 06:42 AM Good morning. Similar to the volatility observed in April, market uncertainty increased in October amid renewed concerns over a potential flare-up in the U.S.–China trade war. Lynn Martin, president ... | 
| date | open | high | low | close | volume | 
|---|---|---|---|---|---|
| 31/10/25 | 1.13 | 1.13 | 1.095 | 1.13 | 286,007 | 
| 30/10/25 | 1.10 | 1.14 | 1.09 | 1.10 | 368,038 | 
| 29/10/25 | 1.16 | 1.17 | 1.12 | 1.14 | 467,701 | 
| 28/10/25 | 1.219 | 1.22 | 1.15 | 1.17 | 508,762 | 
| 27/10/25 | 1.22 | 1.22 | 1.14 | 1.22 | 699,518 | 
| 24/10/25 | 1.16 | 1.20 | 1.15 | 1.19 | 403,153 | 
| 23/10/25 | 1.24 | 1.265 | 1.16 | 1.17 | 816,847 | 
| 22/10/25 | 1.25 | 1.38 | 1.13 | 1.19 | 1,843,087 | 
| 21/10/25 | 1.06 | 1.24 | 1.05 | 1.21 | 2,806,930 | 
| 20/10/25 | 1.05 | 1.08 | 1.035 | 1.05 | 1,390,602 | 
| 
 | 
 | ||||
| 
 | 
 | ||||
| 
 | 
 |